57
36
Growth Score 57 in past quarter
-28 pts
Heat Score 36 in past quarter
-19 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
259138
Neuraxpharm is a Pharmaceutical Company.
- Jörg Dierks: CEOPast Role: Pharmanovia, Chairman of the Board
- Burghard Burczyk: Chief Technology Officer
About the Company
Neuraxpharm develops and commercializes branded and generic CNS pharmaceuticals and nutraceuticals for the treatment and prevention of CNS disorders in main European countries.